Peter Magnusson

Artiklar i tidskrifter

• Wallhagen, M. & Magnusson, P. (2024). Ecological Worldview Among University Staff.  Ethics and the Environment, 29 (1), 29-47. [BibTeX]

Artiklar, forskningsöversikter

• Pergolizzi, J. , LeQuang, J. A. K. , Wagner, M. , Salah, R. , Magnusson, P. & Varrassi, G. (2024). Red Wine as an Aromatase Inhibitor: A Narrative Review.  Cureus, 16 (5). [BibTeX]
• Pergolizzi, J. , LeQuang, J. A. K. , Vortsman, E. , Magnusson, P. , El-Tallawy, S. N. , Wagner, M. , Salah, R. & Varrassi, G. (2024). The Emergence of the Old Drug Captagon as a New Illicit Drug: A Narrative Review.  Cureus, 16 (2). [BibTeX]
• Pergolizzi, J. , LeQuang, J. A. K. , Coluzzi, F. , Magnusson, P. , Lara-Solares, A. & Varrassi, G. (2023). Considerations for Pain Assessments in Cancer Patients: A Narrative Review of the Latin American Perspective.  Cureus, 15 (6). [BibTeX]
• Pergolizzi, J. V. , Breve, F. , Magnusson, P. , LeQuang, J. K. & Varassi, G. (2023). Current and emerging COX inhibitors for treating postoperative pain following oral surgery.  Expert Opinion on Pharmacotherapy, 24 (3), 347-358. [BibTeX]
• Pergolizzi, J. , LeQuang, J. A. K. , Breve, F. , Magnusson, P. & Varrassi, G. (2023). Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review.  Cureus, 15 (1). [BibTeX]
• Pergolizzi, J. , Varrassi, G. , LeQuang, J. A. K. , Breve, F. & Magnusson, P. (2023). Fixed Dose Versus Loose Dose: Analgesic Combinations.  Cureus, 15 (1). [BibTeX]
• Pergolizzi, J. V. , LeQuang, J. A. , Magnusson, P. & Varrassi, G. (2023). Identifying risk factors for chronic postsurgical pain and preventive measures: a comprehensive update.  Expert Review of Neurotherapeutics, 23 (12), 1297-1310. [BibTeX]
• Pergolizzi, J. , LeQuang, J. A. K. , Magnusson, P. , Miller, T. L. , Breve, F. & Varrassi, G. (2023). The New Stealth Drug on the Street: A Narrative Review of Xylazine as a Street Drug.  Cureus, 15 (6). [BibTeX]
• Pergolizzi, J. V. , LeQuang, J. A. , Varrassi, M. , Breve, F. , Magnusson, P. & Varrassi, G. (2023). What Do We Need to Know About Rising Rates of Idiopathic Pulmonary Fibrosis? A Narrative Review and Update.  Advances in Therapy, 40, 1334-1346. [BibTeX]
• Parikh, R. R. , Patel, K. R. , Pergolizzi, J. V. , Breve, F. & Magnusson, P. (2022). Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF).  Cureus, 14 (3). [BibTeX]
• Behzadi, P. , Sameer, A. S. , Nissar, S. , Banday, M. Z. , Gajdács, M. , García-Perdomo, H. A. , Akhtar, K. , Pinheiro, M. & et al. (2022). The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs).  Journal of Immunology Research, 2022. [BibTeX]
• Parikh, R. R. , Breve, F. , Magnusson, P. , Behzadi, P. & Pergolizzi, J. (2022). The Use of Monoclonal Antibody-Based Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia.  Cureus, 14 (6). [BibTeX]